These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32998454)

  • 1. Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells.
    Meng J; Counsell J; Morgan JE
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.
    Meng J; Counsell JR; Reza M; Laval SH; Danos O; Thrasher A; Lochmüller H; Muntoni F; Morgan JE
    Sci Rep; 2016 Jan; 6():19750. PubMed ID: 26813695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
    Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
    Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.
    Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S
    Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
    Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
    Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
    Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS
    Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFβ-dependent pro-fibrotic signaling.
    Caputo L; Granados A; Lenzi J; Rosa A; Ait-Si-Ali S; Puri PL; Albini S
    Skelet Muscle; 2020 May; 10(1):13. PubMed ID: 32359374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase.
    Quenneville SP; Chapdelaine P; Rousseau J; Tremblay JP
    Gene Ther; 2007 Mar; 14(6):514-22. PubMed ID: 17167499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts.
    Meng J; Sweeney NP; Doreste B; Muntoni F; McClure M; Morgan J
    Hum Gene Ther; 2020 Feb; 31(3-4):241-252. PubMed ID: 31801386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of calcium handling and changes in calcium-release properties after mini- or full-length dystrophin forced expression in cultured skeletal myotubes.
    Marchand E; Constantin B; Balghi H; Claudepierre MC; Cantereau A; Magaud C; Mouzou A; Raymond G; Braun S; Cognard C
    Exp Cell Res; 2004 Jul; 297(2):363-79. PubMed ID: 15212940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
    Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
    Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional EGFP-dystrophin fusion proteins for gene therapy vector development.
    Chapdelaine P; Moisset PA; Campeau P; Asselin I; Vilquin JT; Tremblay JP
    Protein Eng; 2000 Sep; 13(9):611-5. PubMed ID: 11054455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-dystrophin efficiently incorporates into the dystrophin protein complex in living cells.
    Draviam RA; Wang B; Li J; Xiao X; Watkins SC
    J Muscle Res Cell Motil; 2006; 27(1):53-67. PubMed ID: 16496225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of myogenic differentiation factors and skeletal muscle proteins in human amnion-derived cells via the forced expression of MYOD1.
    Akizawa Y; Kanno H; Kawamichi Y; Matsuda Y; Ohta H; Fujii H; Matsui H; Saito K
    Brain Dev; 2013 Apr; 35(4):349-55. PubMed ID: 22727434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors can be used for full-length dystrophin gene therapy.
    Counsell JR; Asgarian Z; Meng J; Ferrer V; Vink CA; Howe SJ; Waddington SN; Thrasher AJ; Muntoni F; Morgan JE; Danos O
    Sci Rep; 2017 Mar; 7(1):79. PubMed ID: 28250438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.
    Sardone V; Ellis M; Torelli S; Feng L; Chambers D; Eastwood D; Sewry C; Phadke R; Morgan JE; Muntoni F
    PLoS One; 2018; 13(3):e0194540. PubMed ID: 29579078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
    Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
    Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.